Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double-blind placebo-controlled trial JHM IRB
Description
To investigate the use of Orilissa to treat endometriosis prior to in-vitro fertilization procedures.
Details
Age
Adult
Eligibility
Ages: 18-38 years old Must have diagnosis of endometriosis Must be planning IVF for treatment of infertility
Type of Study
Treatment
Locations
Outpatient CTRC
SGF Colorado - Colorado Springs
SGF Colorado - Denver
Principal Investigator
Nanette Santoro, MD
Study ID
Protocol Number: 19-3115
More information available at ClinicalTrials.gov: NCT04173169
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers